W.H.O. Discontinues Lopinavir and Ritonavir Testing for Covid-19 Treatment

As in the case of hydroxychloroquine, the trials showed that there is no effectiveness in the use of these drugs, when their performance is compared with the standard treatment procedure.

RIO DE JANEIRO, BRAZIL - The World Health Organization (W.H.O.) announced on Saturday, July 4th, that it will discontinue its studies on lopinavir and ritonavir antivirals to treat Covid-19, the disease caused by the novel coronavirus (Sars-Cov-2).

As . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?